Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrosis in scleroderma.

Eugene Y Kissin1, Joseph H Korn

  • 1Section of Rheumatology and Arthritis Center, Boston University School of Medicine, 71 East Concord Street, Boston, MA 02118, USA.

Rheumatic Diseases Clinics of North America
|July 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

En Coup D'une Veine: Anatomy of a Novel Morphea Mimicker.

International journal of dermatology·2025
Same author

Periosteal Manifestations of Osteomyelitis and Arthritis on Ultrasound: A Systematic Review.

Journal of medical ultrasound·2024
Same author

North American musculoskeletal ultrasound scanning protocol of the shoulder, elbow, wrist, and hand: update of a Delphi Consensus Study.

Clinical rheumatology·2022
Same author

Ultrasound evaluation of the Achilles enthesis in inflammatory and non-inflammatory processes: a systematic review and meta-analysis.

Clinical and experimental rheumatology·2022
Same author

North American musculoskeletal ultrasound scanning protocol of the hip, knee, ankle, and foot: update of a Delphi consensus study.

Clinical rheumatology·2021
Same author

Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise.

Seminars in arthritis and rheumatism·2021

Scleroderma fibrosis stems from complex fibroblast interactions, involving immune activation and microvascular damage. Therapies targeting cellular and matrix defects may treat fibrotic complications.

Area of Science:

  • Immunology
  • Cell Biology
  • Dermatology

Background:

  • Fibrosis is a key feature of scleroderma, characterized by excessive extracellular matrix deposition.
  • The precise mechanisms driving fibroblast activation and myofibroblast persistence in scleroderma remain incompletely understood.

Purpose of the Study:

  • To elucidate the complex pathogenesis of fibrosis in scleroderma.
  • To identify key cellular and molecular pathways contributing to fibroblast hyperactivity.

Main Methods:

  • Review and synthesis of current literature on scleroderma pathogenesis.
  • Analysis of fibroblast behavior, including proliferation, apoptosis, and phenotype.
  • Examination of potential contributing factors such as immune response and growth factor signaling.

Related Experiment Videos

Main Results:

  • Fibrosis involves intricate fibroblast-environment interactions, immune activation, and microvascular damage.
  • Myofibroblast phenotype is sustained by differential proliferation and apoptosis, not just acute injury resolution.
  • Potential defects include fibrillin abnormalities, autoantibodies, type II immune responses, endothelial dysfunction, and heightened TGF-beta signaling.

Conclusions:

  • Scleroderma fibrosis results from a multifactorial process involving fibroblast dysregulation.
  • Targeting specific cellular and matrix abnormalities offers a promising therapeutic strategy for scleroderma fibrotic complications.